Key statistics
On Friday, Neogenomics Inc (NEO:NAQ) closed at 16.39, 28.35% above the 52 week low of 12.77 set on Oct 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.39 |
---|---|
High | 16.44 |
Low | 15.39 |
Bid | 16.10 |
Offer | 16.39 |
Previous close | 15.39 |
Average volume | 586.06k |
---|---|
Shares outstanding | 128.36m |
Free float | 126.72m |
P/E (TTM) | -- |
Market cap | 1.98bn USD |
EPS (TTM) | -0.6152 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
- Felicia Williams Joins NeoGenomics Board of Directors
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
- NeoGenomics Reports Third Quarter 2024 Results
- NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
- NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
- NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
- NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
- NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
- NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼